CAS 1839150-56-9

Fórmula: C26H29N7O2

InChI: InChI=1S/C26H29N7O2/c1-31(2)16-22(34)32-14-6-7-19(15-32)33-26-23(25(27)28-17-29-26)24(30-33)18-10-12-21(13-11-18)35-20-8-4-3-5-9-20/h3-5,8-13,17,19H,6-7,14-16H2,1-2H3,(H2,27,28,29)/t19-/m1/s1

Clave InChI: IZNAFSDUTMZGSF-LJQANCHMSA-N

SMILES: CN(C)CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N

CHMFL-FLT3-122

CAS: 1839150-56-9

CHMFL-FLT3-122

Fórmula: C₂₆H₂₉N₇O₂

Pureza: ≥98%

Peso molecular: 471.55

Ref: 54-BUP21493

1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-(dimethylamino)ethanone

CAS: 1839150-56-9

Fórmula: C₂₆H₂₉N₇O₂

Pureza: 98%

Peso molecular: 471.5542

Ref: IN-DA01E3FU

Chmfl-flt3-122

CAS: 1839150-56-9

Chmfl-flt3-122 is a drug that belongs to the class of tyrosine kinase inhibitors. It is an orally administered, potent inhibitor of the FLT3 receptor tyrosine kinase that has shown activity in vivo against a variety of solid tumors, including prostate and breast cancer. Chmfl-flt3-122 inhibits tumor growth by inhibiting cellular proliferation and inducing apoptosis. The drug also inhibits normal hematopoietic cells, but it is not active against normal tissues such as liver or kidney cells.

Fórmula: C₂₆H₂₉N₇O₂

Pureza: Min. 95%

Peso molecular: 471.6 g/mol

Ref: 3D-PYC15056

CHMFL-FLT3-122

CAS: 1839150-56-9

CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia.

Fórmula: C₂₆H₂₉N₇O₂

Pureza: 99.63%

Forma y color: Solid

Peso molecular: 471.55

Ref: TM-T27011